Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain health: time matters in multiple sclerosis.
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
SMAD4 is Involved in the Development of Endotoxin Tolerance in Microglia.
Sensory gating of auditory evoked potentials in rats: effects of repetitive stimulation and the interstimulus interval.
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis.
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.
Multiple sclerosis lesion in the medulla oblongata in a patient with takotsubo cardiomyopathy.
Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients.
Health Literacy and Outcomes in Multiple Sclerosis.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
Early Relapsing Multiple Sclerosis.
Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis.
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.
Focused Ultrasound Treatment of Cervical Lymph Nodes in Rats with EAE: A Pilot Study.
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.
Perception of risk and shared decision making process in multiple sclerosis.
Myelin contrast across lamina at 7T, ex-vivo and in-vivo dataset.
Immune response in peripheral axons delays disease progression in SOD1(G93A) mice.
Differentiation of bone marrow stromal cells into schwann-like cells using dihydrotestosterone combined with a classical induction method.
A Qualitative Study of Multiple Health Behaviors in Adults with Multiple Sclerosis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens.
Patient Management Problem-Preferred Responses.
Pages
« first
‹ previous
…
747
748
749
750
751
752
753
754
755
…
next ›
last »